Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Charcot-Marie-Tooth disease type 2.

J M Vance1

  • 1Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. jeff@dnadoc.mc.duke.edu

Annals of the New York Academy of Sciences
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exome Sequencing of Extended Families with Alzheimer's Disease Identifies Novel Genes Implicated in Cell Immunity and Neuronal Function.

Journal of Alzheimer's disease & Parkinsonism·2017
Same author

Targeted sequencing of ABCA7 identifies splicing, stop-gain and intronic risk variants for Alzheimer disease.

Neuroscience letters·2017
Same author

GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis.

Genes and immunity·2016
Same author

Isolation of genomic DNA from mammalian cells.

Current protocols in human genetics·2008
Same author

Longitudinal follow-up of late-onset Alzheimer disease families.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics·2008
Same author

Polymorphisms of the tumor suppressor gene LSAMP are associated with left main coronary artery disease.

Annals of human genetics·2008

Charcot-Marie-Tooth type 2 (CMT2) lacks unique genes, but Cx32 and P0 contribute to its phenotype. Further research into CMT2 will illuminate peripheral nerve cell interactions and idiopathic neuropathy.

Area of Science:

  • Neuroscience
  • Genetics
  • Peripheral Neuropathy Research

Background:

  • Charcot-Marie-Tooth type 2 (CMT2) is a subtype of inherited peripheral neuropathy.
  • The genetic basis of CMT2 remains largely unknown, with no unique causative genes identified to date.
  • Existing knowledge suggests potential contributions from genes like Cx32 and P0 to the CMT2 phenotype.

Purpose of the Study:

  • To explore the genetic heterogeneity of CMT2.
  • To investigate the roles of Cx32 and P0 in CMT2 pathogenesis.
  • To challenge and refine current classifications of inherited neurological disorders.

Main Methods:

  • Genetic analysis to identify potential CMT2 genes.
  • Phenotypic characterization of CMT2 patients.

Related Experiment Videos

  • Comparative studies with CMT1 to understand disease mechanisms.

    • Main Results:

    • No unique genes definitively identified for CMT2.
    • Evidence suggests Cx32 and P0 play a role in the CMT2 phenotype.
    • CMT2 exhibits significant genetic heterogeneity, exceeding that of CMT1.

    Conclusions:

    • CMT2 presents a complex genetic landscape.
    • Understanding CMT2 requires further investigation into Schwann cell-axon interactions.
    • Research on CMT2 may provide insights into idiopathic neuropathies.